{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:37:17Z","timestamp":1760315837637,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010486","name":"Teijin Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jjcc.2021.08.002","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:32:57Z","timestamp":1629505977000},"page":"558-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Moderate potassium lowering effect of exogenous atrial natriuretic peptide in patients with acute heart failure"],"prefix":"10.1016","volume":"78","author":[{"given":"Masaaki","family":"Konishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2021.08.002_bib0001","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0002","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0003","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamacardio.2016.4733","article-title":"Reduced risk of hyperkalemia during treatment of heart failure with mineralocorticoid receptor antagonists by use of sacubitril\/valsartan compared with enalapril: a secondary analysis of the PARADIGM-HF trial","volume":"2","author":"Desai","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0004","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/978-3-540-68964-5_21","article-title":"Modulation of cGMP in heart failure: a new therapeutic paradigm","volume":"191","author":"Boerrigter","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0005","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.jacc.2020.04.021","article-title":"Abnormalities of potassium in heart failure: JACC state-of-the-art review","volume":"75","author":"Ferreira","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0006","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2014.12.010","article-title":"Hyponatremia in acute decompensated heart failure: depletion versus dilution","volume":"65","author":"Verbrugge","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0007","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.amjcard.2016.08.078","article-title":"Serum potassium levels and outcome in patients with chronic heart failure","volume":"118","author":"Hoss","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0008","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.117.030576","article-title":"Long-term potassium monitoring and dynamics in heart failure and risk of mortality","volume":"137","author":"N\u00fa\u00f1ez","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0009","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1093\/eurheartj\/ehx460","article-title":"Associations of serum potassium levels with mortality in chronic heart failure patients","volume":"38","author":"Aldahl","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0010","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1002\/ehf2.13042","article-title":"Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy","volume":"7","author":"Matsumoto","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0011","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0012","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","volume":"23","author":"Yancy","year":"2017","journal-title":"J Card Fail"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0013","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1681\/ASN.2016101139","article-title":"Diagnosis and treatment of hyponatremia: compilation of the guidelines","volume":"28","author":"Hoorn","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0014","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(85)91207-3","article-title":"Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers","volume":"325","author":"Richards","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.CIR.76.1.115","article-title":"Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function","volume":"76","author":"Saito","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002593","article-title":"Differential response to low-dose dopamine or low-dose nesiritide in acute heart failure with reduced or preserved ejection fraction","volume":"9","author":"Wan","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0017","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1253\/circj.CJ-08-0130","article-title":"Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study","volume":"72","author":"Hata","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0018","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2215\/CJN.09630818","article-title":"Clinical pharmacology in diuretic use","volume":"14","author":"Ellison","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0019","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/ajh\/3.9.668","article-title":"Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects","volume":"3","author":"Rocco","year":"1990","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0020","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1016\/j.cardfail.2008.07.125","article-title":"Protective effect of carperitide on aldosterone in congestive heart failure patients","volume":"14","author":"Tanabe","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.jjcc.2021.08.002_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008687","article-title":"9-year trend in the management of acute heart failure in Japan: a report from the national consortium of acute heart failure registries","volume":"7","author":"Shiraishi","year":"2018","journal-title":"J Am Heart Assoc"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508721001970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508721001970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:05:01Z","timestamp":1760274301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508721001970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0914508721001970"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2021.08.002","relation":{},"ISSN":["0914-5087"],"issn-type":[{"type":"print","value":"0914-5087"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moderate potassium lowering effect of exogenous atrial natriuretic peptide in patients with acute heart failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2021.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}